Full View

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio… - … advances in respiratory …, 2018 - journals.sagepub.com
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …
被引用次数：29 相关文章

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio, R Chiari - THERAPEUTIC …, 2018 - cris.unibo.it
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …
[PDF] core.ac.uk

[PDF][PDF] Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio, R Chiari - 2018 - core.ac.uk
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience.

B Ricciuti, S Baglivo, A De Giglio… - Therapeutic Advances in …, 2018 - europepmc.org
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …
[HTML] nih.gov

[HTML][HTML] Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio… - Therapeutic Advances in …, 2018 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …
[PDF] researchgate.net

[PDF][PDF] Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio, R Chiari - 2018 - researchgate.net
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio… - … in respiratory disease, 2018 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio, R Chiari - Therapeutic Advances in …, 2018 - cir.nii.ac.jp
抄録< jats: p> Epidermal growth factor receptor (EGFR) gene mutations identify a
molecularly defined subset of non-small cell lung cancer (NSCLC) patients who display an …
[PDF] researchgate.net

[PDF][PDF] Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

B Ricciuti, S Baglivo, A De Giglio, R Chiari - 2018 - researchgate.net
Epidermal growth factor receptor (EGFR) gene mutations identify a molecularly defined
subset of non-small cell lung cancer (NSCLC) patients who display an excellent sensitivity to …